These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28342265)

  • 1. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.
    Nagaoki Y; Aikata H; Daijyo K; Teraoka Y; Shinohara F; Nakamura Y; Hatooka M; Morio K; Nakahara T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Chayama K
    Hepatol Res; 2018 Jan; 48(1):51-58. PubMed ID: 28342265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.
    Naeshiro N; Aikata H; Hyogo H; Kan H; Fujino H; Kobayashi T; Fukuhara T; Honda Y; Nakahara T; Ohno A; Miyaki D; Murakami E; Kawaoka T; Tsuge M; Hiraga N; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Chayama K
    Hepatol Res; 2015 Jun; 45(6):656-62. PubMed ID: 25088236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute exacerbation of liver-cirrhosis-associated portal vein thrombosis with direct-acting oral anticoagulant, edoxaban, used as an initial treatment in the early postoperative period after abdominal surgery: a case report.
    Toyoda J; Morioka D; Horii N; Nakayama G; Oyama N; Asano F; Izumisawa Y; Miura M; Sato Y; Endo I
    J Med Case Rep; 2021 Feb; 15(1):52. PubMed ID: 33563326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
    Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
    J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis.
    Suda T; Takatori H; Hayashi T; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Yamashita T; Yamashita T; Mizukoshi E; Honda M; Okumura K; Kozaka K; Kaneko S
    Life (Basel); 2020 Sep; 10(9):. PubMed ID: 32899804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellar hemorrhage in patients treated with edoxaban for portal vein thrombosis after hepatobiliary surgery: a report of two cases.
    Iida H; Miyake T; Tani M; Tanaka T; Kawakami K; Ikuno Y; Mandai R; Shimizu T
    Surg Case Rep; 2020 Dec; 6(1):319. PubMed ID: 33305345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
    Lin GS; Xu Q; Zhao SY; Zhang YX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
    Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
    Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes.
    Yue-Meng W; Li YH; Wu HM; Yang J; Yang LH; Xu Y
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):462-470. PubMed ID: 28110540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
    Hanafy AS; Abd-Elsalam S; Dawoud MM
    Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study.
    Zhang Z; Zhao Y; Li D; Guo M; Li H; Liu R; Cui X
    Thromb J; 2023 Jan; 21(1):13. PubMed ID: 36717831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension.
    Kojima S; Watanabe N; Koizumi J; Kokubu S; Murashima N; Matsutani S; Obara K
    Hepatol Res; 2018 Mar; 48(4):244-254. PubMed ID: 28902450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
    Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.